Ember Therapeutics, Inc.
Other OTCTotal Valuation
Ember Therapeutics, Inc. carries a market capitalization of 398.00, placing it among publicly traded companies globally.
| Market Cap | 398.00 |
| Enterprise Value | N/A |
Share Statistics
Ember Therapeutics, Inc. currently has 3.71M shares outstanding.
| Shares Outstanding | 3.71M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Financial Position
Ember Therapeutics, Inc. maintains a current ratio of 0.01, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.01 |
| Quick Ratio | 0.01 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | -3.00 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -896.10 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Income Statement
EBITDA reached -13,930.00, while operating income came in at -13,930.00.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -13,930.00 |
| Pretax Income | -20,095.00 |
| Net Income | -20,095.00 |
| EBITDA | -13,930.00 |
| EBIT | -13,930.00 |
| Earnings Per Share (EPS) | -0.01 |
Balance Sheet
Total book value stands at -2.93M, with working capital of -252,501.00 providing operational flexibility.
| Cash & Cash Equivalents | 2,302.00 |
| Total Debt | N/A |
| Net Debt | 212,314.00 |
| Equity (Book Value) | -2.93M |
| Book Value Per Share | -0.79 |
| Working Capital | -252,501.00 |
Cash Flow
Ember Therapeutics, Inc. produced -15,030.00 in operating cash flow over the past twelve months.
| Operating Cash Flow | -15,030.00 |
| Capital Expenditures | N/A |
| Free Cash Flow | -15,030.00 |
| FCF Per Share | 0.00 |
Scores
Ember Therapeutics, Inc. posts an Altman Z-Score of -1,935.39, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -1,935.39 |